<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00967967</url>
  </required_header>
  <id_info>
    <org_study_id>CER 20389</org_study_id>
    <nct_id>NCT00967967</nct_id>
  </id_info>
  <brief_title>Validation of the Rhinitis Control Scoring System (RCSS)</brief_title>
  <acronym>RCSS</acronym>
  <official_title>Validation of a Rhinitis Control Tool : the Rhinitis Control Scoring System (RCSS)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Laval University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Laval University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Many patients suffering from allergic rhinitis do not recognize or perceive their symptoms.
      Instruments have been developed to assess quality of life in rhinitis, asthma or both, but
      there is a need to develop validated tools or methods to assess rhinitis control among
      rhinitis and/or asthmatic patients. The aim of this study is to assess the discriminative and
      evaluative properties of the RCSS in asthmatic patients with allergic rhinitis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Allergic asthmatic subjects showing seasonal rhinitis symptoms will be recruited. The
      discriminative (internal consistency, cross sectional construct validity and reliability) and
      evaluative (responsiveness and longitudinal construct validity) properties of the RCSS will
      be evaluated as well as the relationship between rhinitis control and asthma control. RCSS
      will be completed at various time points during the seasonal allergic period.
    </textblock>
  </detailed_description>
  <overall_status>Suspended</overall_status>
  <why_stopped>
    Awaiting results from sub analysis to decide if study continuesé
  </why_stopped>
  <start_date>March 2009</start_date>
  <completion_date type="Anticipated">September 2014</completion_date>
  <primary_completion_date type="Anticipated">June 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Discriminative (internal consistency, cross sectional construct validity and reliability) and evaluative (responsiveness and longitudinal construct validity) properties of the RCSS.</measure>
    <time_frame>March to November 2009</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>The relationship between rhinitis control and asthma control.</measure>
    <time_frame>March to November 2009</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Asthma</condition>
  <condition>Rhinitis</condition>
  <arm_group>
    <arm_group_label>Mometasone furoate and desloratadine</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Mometasone and desloratadine treatment</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Medication Mometasone furoate and desloratadine</intervention_name>
    <description>One month treatment with both drugs</description>
    <arm_group_label>Mometasone furoate and desloratadine</arm_group_label>
    <other_name>Nasonex</other_name>
    <other_name>Aerius</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  asthma

          -  seasonal allergic rhinitis

        Exclusion Criteria:

          -  smoking

          -  nasal polyposis
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Louis-Philippe Boulet, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Institut universitaire de cardiologie et de pneumologie de Québec</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Institut universitaire de cardiologie et de pneumologie de Québec</name>
      <address>
        <city>Québec</city>
        <state>Quebec</state>
        <zip>G1V 4G5</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>May 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 26, 2009</study_first_submitted>
  <study_first_submitted_qc>August 27, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 28, 2009</study_first_posted>
  <last_update_submitted>May 24, 2013</last_update_submitted>
  <last_update_submitted_qc>May 24, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 27, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Laval University</investigator_affiliation>
    <investigator_full_name>Louis-Philippe Boulet</investigator_full_name>
    <investigator_title>Professeur</investigator_title>
  </responsible_party>
  <keyword>control</keyword>
  <keyword>symptoms</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rhinitis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mometasone Furoate</mesh_term>
    <mesh_term>Desloratadine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

